OPIANT PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements

2 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
European Patent Specification EP 1 681 057 B1 – Use of Naloxone for Treating Eating Disorders (Sinclair)
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2009
US Patent Application: Method for Treating Eating Disorders by Selective Extinction with Transdermal Naloxone (Inventor: John David Sinclair)
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2009